Regenerative Medical Technology Group Inc. (RMTG)
SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 14, 2026
as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Jun 30, 2026, Regenerative Medical Technology Group Inc. reported revenue of $4.0M, net income of -$2.9M, and total assets of $5.9M. Every figure below is taken directly from Regenerative Medical Technology Group Inc.'s SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2017–FY2025 · as reported
- FY2017 revenue
- $29,241
- FY2025 revenue
- $5.1M
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2025 | $5.1M | -$7.8M |
| FY2024 | $4.1M | -$5.6M |
| FY2023 | $2.4M | -$9.8M |
| FY2022 | $1.5M | -$5.5M |
| FY2021 | $437,887 | -$12.9M |
| FY2020 | $55,082 | -$5.9M |
| FY2019 | $30,103 | -$2.5M |
| FY2018 | $50,116 | -$2.1M |
| FY2017 | $29,241 | -$377,007 |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Aug 25, 2026 | on EDGAR ↗ |
| 10-Q | Aug 19, 2026 | on EDGAR ↗ |
| NT 10-Q | Aug 14, 2026 | on EDGAR ↗ |
| 10-Q | Jun 9, 2026 | on EDGAR ↗ |
| NT 10-Q | May 15, 2026 | on EDGAR ↗ |
| 10-K | May 14, 2026 | on EDGAR ↗ |
| NT 10-K | Apr 1, 2026 | on EDGAR ↗ |
| 10-Q | Nov 19, 2025 | on EDGAR ↗ |
| 10-Q | Aug 19, 2025 | on EDGAR ↗ |
| 8-K | May 21, 2025 | on EDGAR ↗ |
Balance Sheet
as of Jun 30, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Jun 30, 2026
Per Share & Cash Flow
10-Q (quarterly) · period ended Jun 30, 2026
| EPS (diluted) | $-0.22 | Earnings | source ↗ |
| EPS (basic) | $-0.22 | Earnings | source ↗ |
| Shares Outstanding | 13.7M | Entity | source ↗ |
| Cash from Operations | $331,974 | Net | source ↗ |
| Cash from Financing | -$26,619 | Net | source ↗ |
| Cash from Investing | -$43,499 | Net | source ↗ |
Restatement history
Point-in-time5 of 225 annual fact-keys were materially restated between filings: what Regenerative Medical Technology Group Inc. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.
See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.
Deeper fundamentals
A free API key reaches RMTG’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/RMTG
MCP tool:
get_sec_fundamentals ticker=RMTG - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/RMTG/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=RMTG as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/RMTG/history
MCP tool:
get_fundamentals_history ticker=RMTG - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/RMTG
MCP tool:
get_financial_health ticker=RMTG
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.